Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00285_DB00701_nanopub.RAK00OOOr0f9US8h2vuDTVXGBGb0RhGgyz6MUI0JkWOXM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00285_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00285_DB00701 label "DDI between Venlafaxine and Amprenavir - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Amprenavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00285_DB00701]" assertion.
- drugbank_resource:DB00285_DB00701 identifier "drugbank_resource:DB00285_DB00701" assertion.
- drugbank_resource:DB00285_DB00701 title "DDI between Venlafaxine and Amprenavir - Amprenavir, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Amprenavir is initiated, discontinued, or dose changed." assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB00701 assertion.
- drugbank:DB00285 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB00701 assertion.